Press Resease

Thyroid Gland Disorder Treatment Market - Global Industry Analysis

Thyroid Gland Disorder Treatment Market - by Disease Type (Hypothyroidism, Hyperthyroidism), by Drug Type (Liothyronine, Levothyroxine, Imidazole, Propacil, Others), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

Published Date: 21-Aug-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2881 Status : Published

Global Thyroid Gland Disorder Treatment Market was valued at USD 2,161.4 Million in 2019 and is expected to reach over USD 2,821.8 Million by 2026, growing at a CAGR of around 3.9% during the forecast period from 2020 to 2026

Description

According to the report, the global thyroid gland disorder treatment market was valued at USD 2,161.4 Million in 2019 and is expected to reach over USD 2,821.8 Million by 2026, growing at a CAGR of around 3.9% during the forecast period from 2020 to 2026.

Thyroid disorder affects the thyroid glands which help to regulate various metabolic processes in our body. There is a major increase in thyroid gland disorder incidences and also various disease awareness programs are being organized by the government mainly in the developing countries which can drive the thyroid gland disorder market in the forecast period.

Global Thyroid Gland Disorder Treatment Market: Overview

Thyroid gland disorder treatments are majorly indicated for thyroid problems that take place, particularly in the thyroid gland. Thyroid disorder is mainly defined as an abnormal discharge of thyroid hormones which is likely to play a major role especially in the regulation of metabolism. The thyroid problem mainly occurs due to the absence of iodine.

Global Thyroid Gland Disorder Treatment Market: Growth Factors

The global thyroid gland disorder treatment market is projected to experience a steady increase in patient inhabitants across all developed as well as emerging economies. Factors such as rising pool of geriatrics and a sedentary lifestyle lead to thyroid gland syndrome and also augments the rate of occurrence of autoimmune syndromes such as Hashimoto's thyroiditis and Grave’s disease which, in turn, contribute to the augmented patient populace of thyroid gland syndromes. The increasing patient pool and the unsettled problem of iodine shortage in diets of the individual across numerous up-coming economies are some of the major aspects fuelling the growth and development for the global thyroid gland disorder treatment market.

Developments for innovative therapeutic alternatives from major pharmaceutical companies, growing knowledge amongst individuals about the accessible treatments, and the increasing disposable incomes, as well as affordability of general or other pharmaceutical formulations in up-coming economies, propel the growth of the thyroid gland disorder treatment market. On the other hand, the easy accessibility of generic medicines and high inclination of patients towards substitute therapies such as herbal medicines and thyroid surgery could restrain the opportunities of the global thyroid gland disorder treatment market to a certain extent.

Thyroid Gland Disorder Treatment Market

Global Thyroid Gland Disorder Treatment Market: Segmentation

The global thyroid gland disorder treatment market is majorly fragmented in terms of disease type and drug type. In terms of disease type, the market is categorized into hypothyroidism and hyperthyroidism. Based on the drug kind, the thyroid gland disorder treatment market is classified into liothyronine, levothyroxine, imidazole, propacil, and others.

Global Thyroid Gland Disorder Treatment Market: Regional Analysis

North America is anticipated to dominate the thyroid gland disorder treatment market owing to the existence of the efficient healthcare facilities, greater knowledge levels among individuals, and the abundant availability of treatment alternatives. Strategic partnerships among government organizations and pharmaceutical companies are growing in the region, mainly to generate generic drugs and spread knowledge among healthcare experts. Thus the market in North America is likely to become more lucrative.

The Asia Pacific market is projected to witness a rapid growth rate since producers in this region are particularly focusing on the expansion of low-cost products with higher effectiveness. Furthermore, the global key players are expected to invest in several local companies in this region, majorly due to the lower price of raw material as well as labor.

Global Thyroid Gland Disorder Treatment Market: Competitive Players

Some of the most important market players in the global thyroid gland disorder treatment market are Pfizer Inc., AbbVie, Allergan Plc., Merck & Co., Inc., GlaxoSmithKline Plc., Mylan N.V., RLC Labs, Inc., Novartis AG, Abbott Laboratories, and Sanofi S.A., among others.

Global Thyroid Gland Disorder Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

  • Chapter 1 Preface
    • 1.1 Report Description
    • 1.1 Report Scope
  • Chapter 2 Research Methodology
    • 2.1 Research Methodology
    • 2.2 Secondary Research
    • 2.3 Primary Research
    • 2.4 Models
      • 2.4.1 Company Share Analysis Model
      • 2.4.2 Revenue Based Modelling
    • 2.5 Research Limitations
  • Chapter 3 Executive Summary
    • 3.1 Global Thyroid Gland Disorder Treatment Market, 2016 – 2026 (USD Million)
    • 3.2 Global Thyroid Gland Disorder Treatment Market: Snapshot
  • Chapter 4 Thyroid Gland Disorder Treatment Market – Industry Analysis
    • 4.1 Introduction
    • 4.2 Market Drivers
      • 4.2.1 Driving Factor 1 Analysis
      • 4.2.2 Driving Factor 2 Analysis:
    • 4.3 Market Restraints
      • 4.3.1 Restraining Factor Analysis
    • 4.4 Market Opportunities
      • 4.4.1 Market Opportunity & Use-case Analysis
      • 4.4.2 Use – Cases for Thyroid Gland Disorder Treatment
    • 4.5 Porter’s Five Forces Analysis
    • 4.6 COVID 19 Impact Analysis
      • 4.6.1.1 Impact on Product Development and Technology Adoption
      • 4.6.1.2 Gap Analysis
  • Chapter 5 Investment Proposition Analysis
    • 5.1 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Disease Type
    • 5.2 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Drug Type
    • 5.3 Global Thyroid Gland Disorder Treatment Market Attractiveness, By Region
  • Chapter 6 Competitive Landscape
    • 6.1 Company Market Share Analysis - 2019
      • 6.1.1 Global Thyroid Gland Disorder Treatment Market: Company Market Share, 2019
    • 6.2 Strategic Developments
    • 7.1 Global Thyroid Gland Disorder Treatment Market Overview: By Disease Type
      • 7.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Disease Type, 2019 & 2026
    • 7.2 Global Thyroid Gland Disorder Treatment Market Analysis/Overview –By Disease Type
      • 7.2.1 Hypothyroidism – Overview/Analysis
      • 7.2.2 Hyperthyroidism – Overview/Analysis
    • 7.3 Hypothyroidism
      • 7.3.1 Global Thyroid Gland Disorder Treatment Market for Hypothyroidism, Revenue (USD Million) 2016 - 2026
    • 7.4 Hyperthyroidism
      • 7.4.1 Global Thyroid Gland Disorder Treatment Market for Hyperthyroidism, Revenue (USD Million) 2016 - 2026
    • 8.1 Global Thyroid Gland Disorder Treatment Market Overview: By Drug Type
      • 8.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, By Drug Type, 2019 & 2026
    • 8.2 Global Thyroid Gland Disorder Treatment Market Analysis/Overview –By Drug Type
      • 8.2.1 Liothyronine – Overview/Analysis
      • 8.2.2 Levothyroxine – Overview/Analysis
      • 8.2.3 Imidazule – Overview/Analysis
      • 8.2.4 Propacil – Overview/Analysis
      • 8.2.5 Others – Overview/Analysis
    • 8.3 Liothyronine
      • 8.3.1 Global Thyroid Gland Disorder Treatment Market for Liothyronine, Revenue (USD Million) 2016 - 2026
    • 8.4 Levothyroxine
      • 8.4.1 Global Thyroid Gland Disorder Treatment Market for Levothyroxine, Revenue (USD Million) 2016 - 2026
    • 8.5 Imidazule
      • 8.5.1 Global Thyroid Gland Disorder Treatment Market for Imidazule, Revenue (USD Million) 2016 - 2026
    • 8.6 Propacil
      • 8.6.1 Global Thyroid Gland Disorder Treatment Market for Propacil, Revenue (USD Million) 2016 - 2026
    • 8.7 Others
      • 8.7.1 Global Thyroid Gland Disorder Treatment Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 9 Thyroid Gland Disorder Treatment Market – Regional Analysis
    • 9.1 Global Thyroid Gland Disorder Treatment Market: Regional Overview
      • 9.1.1 Global Thyroid Gland Disorder Treatment Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2 Global Thyroid Gland Disorder Treatment Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 9.2 North America
      • 9.2.1 North America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 9.2.2 North America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.2.3 North America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
      • 9.2.4 North America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
      • 9.2.5 U.S.
      • 9.2.6 Canada
    • 9.3 Europe
      • 9.3.1 Europe Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 9.3.2 Europe Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.3.3 Europe Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
      • 9.3.4 Europe Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
      • 9.3.5 Germany
      • 9.3.6 France
      • 9.3.7 U.K.
      • 9.3.8 Rest of Europe
    • 9.4 Asia Pacific
      • 9.4.1 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 9.4.2 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.4.3 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
      • 9.4.4 Asia Pacific Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
      • 9.4.5 China
      • 9.4.6 Japan
      • 9.4.7 India
      • 9.4.8 Rest of Asia Pacific
    • 9.5 Latin America
      • 9.5.1 Latin America Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 9.5.2 Latin America Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.5.3 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
      • 9.5.4 Latin America Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
      • 9.5.5 Brazil
      • 9.5.6 Rest of Latin America
    • 9.6 The Middle-East and Africa
      • 9.6.1 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 9.6.2 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.6.3 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Disease Type, 2016 – 2026
      • 9.6.4 The Middle-East and Africa Thyroid Gland Disorder Treatment Market Revenue, By Drug Type, 2016 – 2026
      • 9.6.5 GCC Countries
      • 9.6.6 Rest of Middle-East Africa
  • Chapter 10 Company Profiles
    • 10.1 Pfizer Inc.
      • 10.1.1 Company Overview
      • 10.1.2 Financial Overview
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 AbbVie
    • 10.3 Allergan Plc.
    • 10.4 Merck & Co., Inc.
    • 10.5 GlaxoSmithKline Plc.
    • 10.6 Mylan N.V.
    • 10.7 RLC Labs, Inc.
    • 10.8 Novartis AG
    • 10.9 Abbott Laboratories
    • 10.10 Sanofi S.A.

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social